Kevin J. Tracey Biography, Age, Height, Wife, Net Worth, Family
By Natalie Ross
Age, Biography and Wiki
Kevin J. Tracey was born on 10 December, 1957 in Fort Wayne, Indiana. Discover Kevin J. Tracey's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 66 years old?
| Popular As | N/A |
| Occupation | N/A |
| Age | 66 years old |
| Zodiac Sign | Sagittarius |
| Born | 10 December, 1957 |
| Birthday | 10 December |
| Birthplace | Fort Wayne, Indiana |
| Nationality |
We recommend you to check the complete list of Famous People born on 10 December. He is a member of famous with the age 66 years old group.
Kevin J. Tracey Height, Weight & Measurements
At 66 years old, Kevin J. Tracey height not available right now. We will update Kevin J. Tracey's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status | |
|---|---|
| Height | Not Available |
| Weight | Not Available |
| Body Measurements | Not Available |
| Eye Color | Not Available |
| Hair Color | Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family | |
|---|---|
| Parents | Not Available |
| Wife | Not Available |
| Sibling | Not Available |
| Children | Not Available |
Kevin J. Tracey Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Kevin J. Tracey worth at the age of 66 years old? Kevin J. Tracey’s income source is mostly from being a successful . He is from . We have estimated Kevin J. Tracey's net worth , money, salary, income, and assets.
| Net Worth in 2023 | $1 Million - $5 Million |
| Salary in 2023 | Under Review |
| Net Worth in 2022 | Pending |
| Salary in 2022 | Under Review |
| House | Not Available |
| Cars | Not Available |
| Source of Income |
Kevin J. Tracey Social Network
Timeline
Kevin J. Tracey, a neurosurgeon and inventor, is the president and CEO of the Feinstein Institute for Medical Research, professor of neurosurgery and molecular medicine at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and President of the Elmezzi Graduate School of Molecular Medicine in Manhasset, New York. The Public Library of Science Magazine, PLOS Biology, recognized Tracey in 2019 as one of the most cited researchers in the world.
In February 2019, Tracey along with a team led by Tak Mak, PhD and Maureen Cox, PhD, reported that T cell–derived acetylcholine (ACh) play an important role in regulating immunity.
In May 2018, Tracey was part of a team that was first to decode specific signals that the nervous system uses to communicate immune status and alert the brain to inflammation. Identifying these neural signals and what they're communicating about the body's health provides insight into diagnostic and therapeutic targets, and device development.
Further research led Tracey to study the role of the vagus nerve in controlling the immune system. His work led him to hypothesize that stimulating the vagus nerve with electricity would alleviate inflammation. In 2007 he co-founded a company called SetPoint Medical which aimed to develop vagus nerve stimulation devices to treat autoimmune diseases. The company started clinical trials in 2011, and results published in 2016. Additionally in 2011, Tracey and colleagues discovered a memory T cell subset that secretes acetylcholine in the spleen when activated by signals arising in the vagus nerve.
In 1992, Tracey moved to Northwell Health, in Manhasset, New York, where he practiced neurosurgery and established the Laboratory of Biomedical Science (now the Center for Biomedical Science). In 2005 he was appointed president and CEO of the Feinstein Institute for Medical Research, and professor at and president of the Elmezzi Graduate School of Molecular Medicine (Manhasset, New York).
In the early 1980s, Tracey and colleagues described the inflammatory activity of TNF-α and other cytokines, which ultimately led to the discovery and development of disease-modifying antirheumatic drugs for arthritis. A subsequently expanding field of research confirmed that TNF is a mediator of septic shock, but not sepsis. This prompted Tracey to search for another mediator of sepsis, culminating in 1999 by identification of HMGB1, a protein previously known as a DNA-binding transcription factor, as a mediator and drug target in sepsis. Tracey and his team developed a chemical called CNI-1493. He discovered that CNI-1493 tells brain cells to activate a particular nerve, the vagus nerve. Once activated, the nerve turns down TNF production.
Tracey was born in Fort Wayne, Indiana on 10 December 1957. He received his B.S. in chemistry from Boston College in 1979 and his M.D. from Boston University in 1983. From 1983 to 1992 he trained in neurosurgery at the New York Hospital/Cornell University with Russel Patterson. During this time he was also a guest investigator at Rockefeller University.
